Skip to content
2000
image of A Decade of Research on C9orf72 in Frontotemporal Dementia (2014-2024): A Bibliometric Analysis of Global Trends and Hotspots

Abstract

Introduction

Frontotemporal dementia (FTD) is the third most frequent dementia and the leading dementia subtype in individuals under 65. The discovery of (chromosome 9 open reading frame 72) GGGGCC abnormal expansion is a major genetic cause of both FTD and amyotrophic lateral sclerosis (ALS), linking these diseases along a clinicopathological spectrum. This study aimed to depict the research landscape of in FTD over the past decade, track emerging research hotspots, and provide insights into under-researched areas.

Method

Based on the Web of Science database, a bibliometric analysis was conducted to explore publication trends, key contributors, funding sources, journal categories, co-authorship networks, and keyword co-occurrence, clustering, and bursts.

Results

A total of 1,220 articles were identified, with sustained output of over 100 articles annually. The majority of contributions and funding support came from North America and Europe. Hot research themes included hexanucleotide repeats, nucleocytoplasmic transport, disease mechanisms, and therapeutic targets.

Discussion

North America and Europe were highly productive, supported by higher regional prevalence, genetic burden, and robust funding. Ploy-GR in cerebrospinal fluid has emerged as a diagnostic biomarker. Pathogenic mechanisms remain complex, involving both gain- and loss-of-function effects. Metformin and antisense oligonucleotides were considered as potential therapeutics. Further research is needed in underrepresented populations and on the translational potential of emerging molecular targets.

Conclusion

This study offers a comprehensive overview of current trends and future directions over the past decade in related FTD research, allowing researchers—particularly those new to the area—to quickly understand the current landscape.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X388118250808030811
2025-08-28
2025-11-04

  • From This Site

    /content/journals/cn/10.2174/011570159X388118250808030811
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Bang J. Spina S. Miller B.L. Frontotemporal dementia. Lancet 2015 386 10004 1672 1682 10.1016/S0140‑6736(15)00461‑4 26595641
    [Google Scholar]
  2. Vieira R.T. Caixeta L. Machado S. Silva A.C. Nardi A.E. Arias-Carrión O. Carta M.G. Epidemiology of early-onset dementia: A review of the literature. Clin. Pract. Epidemiol. Ment. Health 2013 9 1 88 95 10.2174/1745017901309010088 23878613
    [Google Scholar]
  3. Rascovsky K. Hodges J.R. Knopman D. Mendez M.F. Kramer J.H. Neuhaus J. van Swieten J.C. Seelaar H. Dopper E.G.P. Onyike C.U. Hillis A.E. Josephs K.A. Boeve B.F. Kertesz A. Seeley W.W. Rankin K.P. Johnson J.K. Gorno-Tempini M.L. Rosen H. Prioleau-Latham C.E. Lee A. Kipps C.M. Lillo P. Piguet O. Rohrer J.D. Rossor M.N. Warren J.D. Fox N.C. Galasko D. Salmon D.P. Black S.E. Mesulam M. Weintraub S. Dickerson B.C. Diehl-Schmid J. Pasquier F. Deramecourt V. Lebert F. Pijnenburg Y. Chow T.W. Manes F. Grafman J. Cappa S.F. Freedman M. Grossman M. Miller B.L. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011 134 9 2456 2477 10.1093/brain/awr179 21810890
    [Google Scholar]
  4. Gorno-Tempini M.L. Hillis A.E. Weintraub S. Kertesz A. Mendez M. Cappa S.F. Ogar J.M. Rohrer J.D. Black S. Boeve B.F. Manes F. Dronkers N.F. Vandenberghe R. Rascovsky K. Patterson K. Miller B.L. Knopman D.S. Hodges J.R. Mesulam M.M. Grossman M. Classification of primary progressive aphasia and its variants. Neurology 2011 76 11 1006 1014 10.1212/WNL.0b013e31821103e6 21325651
    [Google Scholar]
  5. Elahi F.M. Miller B.L. A clinicopathological approach to the diagnosis of dementia. Nat. Rev. Neurol. 2017 13 8 457 476 10.1038/nrneurol.2017.96 28708131
    [Google Scholar]
  6. Hogan D.B. Jetté N. Fiest K.M. Roberts J.I. Pearson D. Smith E.E. Roach P. Kirk A. Pringsheim T. Maxwell C.J. The prevalence and incidence of frontotemporal dementia: A Systematic Review. Can. J. Neurol. Sci. 2016 43 S1 S96 S109 10.1017/cjn.2016.25 27307130
    [Google Scholar]
  7. Mercy L. Hodges J.R. Dawson K. Barker R.A. Brayne C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 2008 71 19 1496 1499 10.1212/01.wnl.0000334277.16896.fa 18981371
    [Google Scholar]
  8. Strong M.J. Abrahams S. Goldstein L.H. Woolley S. Mclaughlin P. Snowden J. Mioshi E. Roberts-South A. Benatar M. HortobáGyi, T.; Rosenfeld, J.; Silani, V.; Ince, P.G.; Turner, M.R. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017 18 3-4 153 174 10.1080/21678421.2016.1267768 28054827
    [Google Scholar]
  9. de Carvalho M. Dengler R. Eisen A. England J.D. Kaji R. Kimura J. Mills K. Mitsumoto H. Nodera H. Shefner J. Swash M. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008 119 3 497 503 10.1016/j.clinph.2007.09.143 18164242
    [Google Scholar]
  10. Brooks B.R. Miller R.G. Swash M. Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000 1 5 293 299 10.1080/146608200300079536 11464847
    [Google Scholar]
  11. Ducharme S. Dols A. Laforce R. Devenney E. Kumfor F. van den Stock J. Dallaire-Théroux C. Seelaar H. Gossink F. Vijverberg E. Huey E. Vandenbulcke M. Masellis M. Trieu C. Onyike C. Caramelli P. de Souza L.C. Santillo A. Waldö M.L. Landin-Romero R. Piguet O. Kelso W. Eratne D. Velakoulis D. Ikeda M. Perry D. Pressman P. Boeve B. Vandenberghe R. Mendez M. Azuar C. Levy R. Le Ber I. Baez S. Lerner A. Ellajosyula R. Pasquier F. Galimberti D. Scarpini E. van Swieten J. Hornberger M. Rosen H. Hodges J. Diehl-Schmid J. Pijnenburg Y. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain 2020 143 6 1632 1650 10.1093/brain/awaa018 32129844
    [Google Scholar]
  12. Goldman J.S. Farmer J.M. Wood E.M. Johnson J.K. Boxer A. Neuhaus J. Lomen-Hoerth C. Wilhelmsen K.C. Lee V.M.Y. Grossman M. Miller B.L. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005 65 11 1817 1819 10.1212/01.wnl.0000187068.92184.63 16344531
    [Google Scholar]
  13. Rohrer J.D. Guerreiro R. Vandrovcova J. Uphill J. Reiman D. Beck J. Isaacs A.M. Authier A. Ferrari R. Fox N.C. Mackenzie I.R.A. Warren J.D. de Silva R. Holton J. Revesz T. Hardy J. Mead S. Rossor M.N. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009 73 18 1451 1456 10.1212/WNL.0b013e3181bf997a 19884572
    [Google Scholar]
  14. Seelaar H. Kamphorst W. Rosso S.M. Azmani A. Masdjedi R. de Koning I. Maat-Kievit J.A. Anar B. Kaat L.D. Breedveld G.J. Dooijes D. Rozemuller J.M. Bronner I.F. Rizzu P. van Swieten J.C. Distinct genetic forms of frontotemporal dementia. Neurology 2008 71 16 1220 1226 10.1212/01.wnl.0000319702.37497.72 18703462
    [Google Scholar]
  15. Renton A.E. Majounie E. Waite A. Simón-Sánchez J. Rollinson S. Gibbs J.R. Schymick J.C. Laaksovirta H. van Swieten J.C. Myllykangas L. Kalimo H. Paetau A. Abramzon Y. Remes A.M. Kaganovich A. Scholz S.W. Duckworth J. Ding J. Harmer D.W. Hernandez D.G. Johnson J.O. Mok K. Ryten M. Trabzuni D. Guerreiro R.J. Orrell R.W. Neal J. Murray A. Pearson J. Jansen I.E. Sondervan D. Seelaar H. Blake D. Young K. Halliwell N. Callister J.B. Toulson G. Richardson A. Gerhard A. Snowden J. Mann D. Neary D. Nalls M.A. Peuralinna T. Jansson L. Isoviita V.M. Kaivorinne A.L. Hölttä-Vuori M. Ikonen E. Sulkava R. Benatar M. Wuu J. Chiò A. Restagno G. Borghero G. Sabatelli M. Heckerman D. Rogaeva E. Zinman L. Rothstein J.D. Sendtner M. Drepper C. Eichler E.E. Alkan C. Abdullaev Z. Pack S.D. Dutra A. Pak E. Hardy J. Singleton A. Williams N.M. Heutink P. Pickering-Brown S. Morris H.R. Tienari P.J. Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011 72 2 257 268 10.1016/j.neuron.2011.09.010 21944779
    [Google Scholar]
  16. DeJesus-Hernandez M. Mackenzie I.R. Boeve B.F. Boxer A.L. Baker M. Rutherford N.J. Nicholson A.M. Finch N.A. Flynn H. Adamson J. Kouri N. Wojtas A. Sengdy P. Hsiung G.Y.R. Karydas A. Seeley W.W. Josephs K.A. Coppola G. Geschwind D.H. Wszolek Z.K. Feldman H. Knopman D.S. Petersen R.C. Miller B.L. Dickson D.W. Boylan K.B. Graff-Radford N.R. Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011 72 2 245 256 10.1016/j.neuron.2011.09.011 21944778
    [Google Scholar]
  17. Balendra R. Isaacs A.M. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 2018 14 9 544 558 10.1038/s41582‑018‑0047‑2 30120348
    [Google Scholar]
  18. Onyike C.U. Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int. Rev. Psychiatry 2013 25 2 130 137 10.3109/09540261.2013.776523 23611343
    [Google Scholar]
  19. Clarke A.J. Brodtmann A. Irish M. Mowszowski L. Radford K. Naismith S.L. Mok V.C.T. Kiernan M.C. Halliday G.M. Ahmed R.M. Risk factors for the neurodegenerative dementias in the Western Pacific region. Lancet Reg. Health. West Pac 2024 50 101051 10.1016/j.lanwpc.2024.101051 39399869
    [Google Scholar]
  20. Jiang Y. Jiao B. Xiao X. Shen L. Genetics of frontotemporal dementia in China. Amyotroph. Lateral Scler. Frontotemporal Degener. 2021 22 5-6 321 335 10.1080/21678421.2021.1880596 33538206
    [Google Scholar]
  21. Jiao B. Tang B. Liu X. Yan X. Zhou L. Yang Y. Wang J. Xia K. Shen L. Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China. Neurobiol. Aging 2014 35 4 936.e19 936.e22 10.1016/j.neurobiolaging.2013.10.001 24269022
    [Google Scholar]
  22. Burrell J.R. Halliday G.M. Kril J.J. Ittner L.M. Götz J. Kiernan M.C. Hodges J.R. The frontotemporal dementia-motor neuron disease continuum. Lancet 2016 388 10047 919 931 10.1016/S0140‑6736(16)00737‑6 26987909
    [Google Scholar]
  23. Lozano S. Calzada-Infante L. Adenso-Díaz B. García S. Complex network analysis of keywords co-occurrence in the recent efficiency analysis literature. Scientometrics 2019 120 2 609 629 10.1007/s11192‑019‑03132‑w
    [Google Scholar]
  24. Logroscino G. Piccininni M. Graff C. Hardiman O. Ludolph A.C. Moreno F. Otto M. Remes A.M. Rowe J.B. Seelaar H. Solje E. Stefanova E. Traykov L. Jelic V. Rydell M.T. Pender N. Anderl-Straub S. Barandiaran M. Gabilondo A. Krüger J. Murley A.G. Rittman T. van der Ende E.L. van Swieten J.C. Hartikainen P. Stojmenović G.M. Mehrabian S. Benussi L. Alberici A. Dell’Abate M.T. Zecca C. Borroni B. Belezhanska D. Bianchetti A. Binetti G. Cotelli M. Cotelli M.S. Dreharova I. Filardi M. Fostinelli S. Ghidoni R. Gnoni V. Nacheva G. Novaković I. Padovani A. Popivanov I. Raycheva M. Stockton K. Stoyanova K. Suhonen N-M. Tainta M. Toncheva D. Urso D. Zlatareva D. Zulaica M. Incidence of syndromes associated with frontotemporal lobar degeneration in 9 european countries. JAMA Neurol. 2023 80 3 279 286 10.1001/jamaneurol.2022.5128 36716024
    [Google Scholar]
  25. Tang M. Gu X. Wei J. Jiao B. Zhou L. Zhou Y. Weng L. Yan X. Tang B. Xu J. Shen L. Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia. Neurobiol. Aging 2016 46 235.e11 235.e15 10.1016/j.neurobiolaging.2016.05.013 27311648
    [Google Scholar]
  26. Knopman D.S. Roberts R.O. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J. Mol. Neurosci. 2011 45 3 330 335 10.1007/s12031‑011‑9538‑y 21584654
    [Google Scholar]
  27. Coyle-Gilchrist I.T.S. Dick K.M. Patterson K. Vázquez Rodríquez P. Wehmann E. Wilcox A. Lansdall C.J. Dawson K.E. Wiggins J. Mead S. Brayne C. Rowe J.B. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 2016 86 18 1736 1743 10.1212/WNL.0000000000002638 27037234
    [Google Scholar]
  28. Ratnavalli E. Brayne C. Dawson K. Hodges J.R. The prevalence of frontotemporal dementia. Neurology 2002 58 11 1615 1621 10.1212/WNL.58.11.1615 12058088
    [Google Scholar]
  29. Stevens T. Livingston G. Kitchen G. Manela M. Walker Z. Katona C. Islington study of dementia subtypes in the community. Br. J. Psychiatry 2002 180 3 270 276 10.1192/bjp.180.3.270 11872521
    [Google Scholar]
  30. Harvey R.J. Skelton-Robinson M. Rossor M.N. The prevalence and causes of dementia in people under the age of 65 years. J. Neurol. Neurosurg. Psychiatry 2003 74 9 1206 1209 10.1136/jnnp.74.9.1206 12933919
    [Google Scholar]
  31. Rosso S.M. Donker Kaat L. Baks T. Joosse M. de Koning I. Pijnenburg Y. de Jong D. Dooijes D. Kamphorst W. Ravid R. Niermeijer M.F. Verheij F. Kremer H.P. Scheltens P. van Duijn C.M. Heutink P. van Swieten J.C. Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population-based study. Brain 2003 126 9 2016 2022 10.1093/brain/awg204 12876142
    [Google Scholar]
  32. Borroni B. Alberici A. Grassi M. Rozzini L. Turla M. Zanetti O. Bianchetti A. Gilberti N. Bonvicini C. Volta G.D. Rozzini R. Padovani A. Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. Alzheimer Dis. Assoc. Disord. 2011 25 4 341 344 10.1097/WAD.0b013e3182147f80 21399481
    [Google Scholar]
  33. Borroni B. Alberici A. Grassi M. Turla M. Zanetti O. Bianchetti A. Volta G.D. Rozzini R. Gilberti N. Bellelli G. Padovani A. Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy. J. Alzheimers Dis. 2010 19 1 111 116 10.3233/JAD‑2010‑1208 20061630
    [Google Scholar]
  34. Gilberti N. Turla M. Alberici A. Bertasi V. Civelli P. Archetti S. Padovani A. Borroni B. Prevalence of frontotemporal lobar degeneration in an isolated population: The Vallecamonica study. Neurol. Sci. 2012 33 4 899 904 10.1007/s10072‑011‑0865‑0 22127750
    [Google Scholar]
  35. Kivipelto M. Helkala E.L. Laakso M.P. Hänninen T. Hallikainen M. Alhainen K. Iivonen S. Mannermaa A. Tuomilehto J. Nissinen A. Soininen H. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann. Intern. Med. 2002 137 3 149 155 10.7326/0003‑4819‑137‑3‑200208060‑00006 12160362
    [Google Scholar]
  36. Gurvit H. Emre M. Tinaz S. Bilgic B. Hanagasi H. Sahin H. Gurol E. Kvaloy J.T. Harmanci H. The prevalence of dementia in an urban Turkish population. Am. J. Alzheimers Dis. Other Demen. 2008 23 1 67 76 10.1177/1533317507310570 18276959
    [Google Scholar]
  37. Herrera E. Caramelli P. Silveira A.S.B. Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis. Assoc. Disord. 2002 16 2 103 108 10.1097/00002093‑200204000‑00007 12040305
    [Google Scholar]
  38. Ikeda M. Hokoishi K. Maki N. Nebu A. Tachibana N. Komori K. Shigenobu K. Fukuhara R. Tanabe H. Increased prevalence of vascular dementia in Japan. Neurology 2001 57 5 839 844 10.1212/WNL.57.5.839 11552014
    [Google Scholar]
  39. Ikejima C. Yasuno F. Mizukami K. Sasaki M. Tanimukai S. Asada T. Prevalence and causes of early-onset dementia in Japan: A population-based study. Stroke 2009 40 8 2709 2714 10.1161/STROKEAHA.108.542308 19478230
    [Google Scholar]
  40. Wada-Isoe K. Uemura Y. Suto Y. Doi K. Imamura K. Hayashi A. Kitayama M. Watanabe Y. Adachi Y. Nakashima K. Prevalence of dementia in the rural island town of Ama-cho, Japan. Neuroepidemiology 2009 32 2 101 106 10.1159/000177035 19039242
    [Google Scholar]
  41. Yamada T. Hattori H. Miura A. Tanabe M. Yamori Y. Prevalence of Alzheimer’s disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin. Neurosci. 2001 55 1 21 25 10.1046/j.1440‑1819.2001.00779.x 11235852
    [Google Scholar]
  42. Gislason T.B. Sjögren M. Larsson L. Skoog I. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds. J. Neurol. Neurosurg. Psychiatry 2003 74 7 867 871 10.1136/jnnp.74.7.867 12810769
    [Google Scholar]
  43. Andreasen N. Blennow K. Sjödin C. Winblad B. Svärdsudd K. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project. Neuroepidemiology 1999 18 3 144 155 10.1159/000026206 10202268
    [Google Scholar]
  44. Ibach B. Koch H. Koller M. Wolfersdorf M. Hospital admission circumstances and prevalence of frontotemporal lobar degeneration: A multicenter psychiatric state hospital study in Germany. Dement. Geriatr. Cogn. Disord. 2003 16 4 253 264 10.1159/000072810 14512721
    [Google Scholar]
  45. Gascón-Bayarri J. Reñé R. Del Barrio J.L. De Pedro-Cuesta J. Ramón J.M. Manubens J.M. Sánchez C. Hernández M. Estela J. Juncadella M. Rubio F.R. Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology 2007 28 4 224 234 10.1159/000108597 17878737
    [Google Scholar]
  46. Banerjee T.K. Mukherjee C.S. Dutt A. Shekhar A. Hazra A. Cognitive dysfunction in an urban Indian population-some observations. Neuroepidemiology 2008 31 2 109 114 10.1159/000146252 18753798
    [Google Scholar]
  47. Lee D.Y. Lee J.H. Ju Y.S. Kang Uk Lee M.D. Kim K.W. Jhoo J.H. Yoon J.C. Ha J. Woo J.I. The prevalence of dementia in older people in an urban population of Korea: The Seoul study. J. Am. Geriatr. Soc. 2002 50 7 1233 1239 10.1046/j.1532‑5415.2002.50310.x 12133018
    [Google Scholar]
  48. Withall A. Draper B. Seeher K. Brodaty H. Koopmans R. Rosness T. The prevalence and causes of younger onset dementia in Eastern Sydney, Australia. Int. Psychogeriatr. 2014 26 12 1955 1965 10.1017/S1041610214001835 25307142
    [Google Scholar]
  49. Knopman D.S. Petersen R.C. Edland S.D. Cha R.H. Rocca W.A. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004 62 3 506 508 10.1212/01.WNL.0000106827.39764.7E 14872045
    [Google Scholar]
  50. Phung T.K.T. Waltoft B.L. Kessing L.V. Mortensen P.B. Waldemar G. Time trend in diagnosing dementia in secondary care. Dement. Geriatr. Cogn. Disord. 2010 29 2 146 153 10.1159/000269933 20150733
    [Google Scholar]
  51. Garre-Olmo J. Genís Batlle D. del Mar Fernández M. Marquez Daniel F. de Eugenio Huélamo R. Casadevall T. Turbau Recio J. Turon Estrada A. López-Pousa S. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology 2010 75 14 1249 1255 10.1212/WNL.0b013e3181f5d4c4 20810999
    [Google Scholar]
  52. Ravaglia G. Forti P. Maioli F. Martelli M. Servadei L. Brunetti N. Dalmonte E. Bianchin M. Mariani E. Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005 64 9 1525 1530 10.1212/01.WNL.0000160107.02316.BF 15883312
    [Google Scholar]
  53. Nitrini R. Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis. Assoc. Disord. 2004 18 4 241 246 15592138
    [Google Scholar]
  54. Greaves C.V. Rohrer J.D. An update on genetic frontotemporal dementia. J. Neurol. 2019 266 8 2075 2086 10.1007/s00415‑019‑09363‑4 31119452
    [Google Scholar]
  55. Hinz F.I. Geschwind D.H. Molecular genetics of neurodegenerative dementias. Cold Spring Harb. Perspect. Biol. 2017 9 4 a023705 10.1101/cshperspect.a023705 27940516
    [Google Scholar]
  56. Nan H. Kim Y.J. Chu M. Li D. Li J. Jiang D. Wu Y. Ohtsuka T. Wu L. Genetic and clinical landscape of Chinese frontotemporal dementia: Dominance of TBK1 and OPTN mutations. Alzheimers Res. Ther. 2024 16 1 127 10.1186/s13195‑024‑01493‑w 38872230
    [Google Scholar]
  57. Jiao B. Xiao T. Hou L. Gu X. Zhou Y. Zhou L. Tang B. Xu J. Shen L. High prevalence of CHCHD10 mutation in =ients with frontotemporal dementia from China. Brain 2016 139 4 e21 10.1093/brain/awv367 26719383
    [Google Scholar]
  58. Lattante S. Ciura S. Rouleau G.A. Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD). Trends Genet. 2015 31 5 263 273 10.1016/j.tig.2015.03.005 25869998
    [Google Scholar]
  59. Devenney E. Hornberger M. Irish M. Mioshi E. Burrell J. Tan R. Kiernan M.C. Hodges J.R. Frontotemporal dementia associated with the C9ORF72 mutation: A unique clinical profile. JAMA Neurol. 2014 71 3 331 339 10.1001/jamaneurol.2013.6002 24445580
    [Google Scholar]
  60. Snowden J.S. Adams J. Harris J. Thompson J.C. Rollinson S. Richardson A. Jones M. Neary D. Mann D.M. Pickering-Brown S. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015 16 7-8 497 505 10.3109/21678421.2015.1074700 26473392
    [Google Scholar]
  61. Snowden J.S. Rollinson S. Thompson J.C. Harris J.M. Stopford C.L. Richardson A.M.T. Jones M. Gerhard A. Davidson Y.S. Robinson A. Gibbons L. Hu Q. DuPlessis D. Neary D. Mann D.M.A. Pickering-Brown S.M. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012 135 3 693 708 10.1093/brain/awr355 22300873
    [Google Scholar]
  62. Glasmacher S.A. Wong C. Pearson I.E. Pal S. Survival and prognostic factors in C9orf72 repeat expansion carriers. JAMA Neurol. 2020 77 3 367 376 10.1001/jamaneurol.2019.3924 31738367
    [Google Scholar]
  63. Meeter L.H. Dopper E.G. Jiskoot L.C. Sanchez-Valle R. Graff C. Benussi L. Ghidoni R. Pijnenburg Y.A. Borroni B. Galimberti D. Laforce R.J. Masellis M. Vandenberghe R. Ber I.L. Otto M. van Minkelen R. Papma J.M. Rombouts S.A. Balasa M. Öijerstedt L. Jelic V. Dick K.M. Cash D.M. Harding S.R. Jorge Cardoso M. Ourselin S. Rossor M.N. Padovani A. Scarpini E. Fenoglio C. Tartaglia M.C. Lamari F. Barro C. Kuhle J. Rohrer J.D. Teunissen C.E. van Swieten J.C. Neurofilament light chain: A biomarker for genetic frontotemporal dementia. Ann. Clin. Transl. Neurol. 2016 3 8 623 636 10.1002/acn3.325 27606344
    [Google Scholar]
  64. Irwin D.J. McMillan C.T. Brettschneider J. Libon D.J. Powers J. Rascovsky K. Toledo J.B. Boller A. Bekisz J. Chandrasekaran K. Wood E.M. Shaw L.M. Woo J.H. Cook P.A. Wolk D.A. Arnold S.E. Van Deerlin V.M. McCluskey L.F. Elman L. Lee V.M.Y. Trojanowski J.Q. Grossman M. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2013 84 2 163 169 10.1136/jnnp‑2012‑303507 23117491
    [Google Scholar]
  65. Cistaro A. Pagani M. Montuschi A. Calvo A. Moglia C. Canosa A. Restagno G. Brunetti M. Traynor B.J. Nobili F. Carrara G. Fania P. Lopiano L. Valentini M.C. Chiò A. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur. J. Nucl. Med. Mol. Imaging 2014 41 5 844 852 10.1007/s00259‑013‑2667‑5 24445987
    [Google Scholar]
  66. Lee S.E. Khazenzon A.M. Trujillo A.J. Guo C.C. Yokoyama J.S. Sha S.J. Takada L.T. Karydas A.M. Block N.R. Coppola G. Pribadi M. Geschwind D.H. Rademakers R. Fong J.C. Weiner M.W. Boxer A.L. Kramer J.H. Rosen H.J. Miller B.L. Seeley W.W. Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain 2014 137 11 3047 3060 10.1093/brain/awu248 25273996
    [Google Scholar]
  67. Snowden J.S. Changing perspectives on frontotemporal dementia: A review. J. Neuropsychol. 2023 17 2 211 234 10.1111/jnp.12297 36315040
    [Google Scholar]
  68. Brettschneider J. Del Tredici K. Toledo J.B. Robinson J.L. Irwin D.J. Grossman M. Suh E. Van Deerlin V.M. Wood E.M. Baek Y. Kwong L. Lee E.B. Elman L. McCluskey L. Fang L. Feldengut S. Ludolph A.C. Lee V.M.Y. Braak H. Trojanowski J.Q. Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013 74 1 20 38 10.1002/ana.23937 23686809
    [Google Scholar]
  69. Cook C.N. Wu Y. Odeh H.M. Gendron T.F. Jansen-West K. del Rosso G. Yue M. Jiang P. Gomes E. Tong J. Daughrity L.M. Avendano N.M. Castanedes-Casey M. Shao W. Oskarsson B. Tomassy G.S. McCampbell A. Rigo F. Dickson D.W. Shorter J. Zhang Y.J. Petrucelli L. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med. 2020 12 559 eabb3774 10.1126/scitranslmed.abb3774 32878979
    [Google Scholar]
  70. Cooper-Knock J. Hewitt C. Highley J.R. Brockington A. Milano A. Man S. Martindale J. Hartley J. Walsh T. Gelsthorpe C. Baxter L. Forster G. Fox M. Bury J. Mok K. McDermott C.J. Traynor B.J. Kirby J. Wharton S.B. Ince P.G. Hardy J. Shaw P.J. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 2012 135 3 751 764 10.1093/brain/awr365 22366792
    [Google Scholar]
  71. Schipper L.J. Raaphorst J. Aronica E. Baas F. de Haan R. de Visser M. Troost D. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C 9 ORF 72 hexanucleotide repeat expansion: A systematic neuropathological review. Neuropathol. Appl. Neurobiol. 2016 42 6 547 560 10.1111/nan.12284 26373655
    [Google Scholar]
  72. Lehmer C. Oeckl P. Weishaupt J.H. Volk A.E. Diehl-Schmid J. Schroeter M.L. Lauer M. Kornhuber J. Levin J. Fassbender K. Landwehrmeyer B. Schludi M.H. Arzberger T. Kremmer E. Flatley A. Feederle R. Steinacker P. Weydt P. Ludolph A.C. Edbauer D. Otto M. Poly‐ GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. EMBO Mol. Med. 2017 9 7 859 868 10.15252/emmm.201607486 28408402
    [Google Scholar]
  73. Quaegebeur A. Glaria I. Lashley T. Isaacs A.M. Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity. Acta Neuropathol. Commun. 2020 8 1 184 10.1186/s40478‑020‑01036‑y 33168090
    [Google Scholar]
  74. Rohrer J.D. Isaacs A.M. Mizielinska S. Mead S. Lashley T. Wray S. Sidle K. Fratta P. Orrell R.W. Hardy J. Holton J. Revesz T. Rossor M.N. Warren J.D. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2015 14 3 291 301 10.1016/S1474‑4422(14)70233‑9 25638642
    [Google Scholar]
  75. Zu T. Guo S. Bardhi O. Ryskamp D.A. Li J. Khoramian Tusi S. Engelbrecht A. Klippel K. Chakrabarty P. Nguyen L. Golde T.E. Sonenberg N. Ranum L.P.W. Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. Proc. Natl. Acad. Sci. USA 2020 117 31 18591 18599 10.1073/pnas.2005748117 32690681
    [Google Scholar]
  76. Tran H. Moazami M.P. Yang H. McKenna-Yasek D. Douthwright C.L. Pinto C. Metterville J. Shin M. Sanil N. Dooley C. Puri A. Weiss A. Wightman N. Gray-Edwards H. Marosfoi M. King R.M. Kenderdine T. Fabris D. Bowser R. Watts J.K. Brown R.H. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nat. Med. 2022 28 1 117 124 10.1038/s41591‑021‑01557‑6 34949835
    [Google Scholar]
/content/journals/cn/10.2174/011570159X388118250808030811
Loading
A Decade of Research on C9orf72 in Frontotemporal Dementia (2014-2024): A Bibliometric Analysis of Global Trends and Hotspots
Bentham Science Publishers ; https://doi.org/10.2174/011570159X388118250808030811
/content/journals/cn/10.2174/011570159X388118250808030811
/content/journals/cn/10.2174/011570159X388118250808030811
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: C9orf72 ; citespace ; data visualization ; frontotemporal dementia ; hotspots ; Bibliometric analysis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test